Does CARBOPLATIN Cause Second primary malignancy? 395 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 395 reports of Second primary malignancy have been filed in association with CARBOPLATIN (Carboplatin). This represents 0.5% of all adverse event reports for CARBOPLATIN.
395
Reports of Second primary malignancy with CARBOPLATIN
0.5%
of all CARBOPLATIN reports
113
Deaths
99
Hospitalizations
How Dangerous Is Second primary malignancy From CARBOPLATIN?
Of the 395 reports, 113 (28.6%) resulted in death, 99 (25.1%) required hospitalization, and 59 (14.9%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARBOPLATIN. However, 395 reports have been filed with the FAERS database.
What Other Side Effects Does CARBOPLATIN Cause?
Off label use (6,100)
Neutropenia (5,314)
Anaemia (5,312)
Febrile neutropenia (4,888)
Nausea (4,588)
Disease progression (4,538)
Thrombocytopenia (4,483)
Malignant neoplasm progression (4,177)
Diarrhoea (4,154)
Dyspnoea (3,494)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which CARBOPLATIN Alternatives Have Lower Second primary malignancy Risk?
CARBOPLATIN vs CARBOPROST TROMETHAMINE
CARBOPLATIN vs CARBOXYMETHYLCELLULOSE
CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\GLYCERIN
CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\GLYCERIN\POLYSORBATE 80
CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\HYPROMELLOSES